These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15364960)

  • 1. Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis.
    Bentele M; Lavrik I; Ulrich M; Stösser S; Heermann DW; Kalthoff H; Krammer PH; Eils R
    J Cell Biol; 2004 Sep; 166(6):839-51. PubMed ID: 15364960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells.
    Neumann L; Pforr C; Beaudouin J; Pappa A; Fricker N; Krammer PH; Lavrik IN; Eils R
    Mol Syst Biol; 2010; 6():352. PubMed ID: 20212524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model.
    Schleich K; Warnken U; Fricker N; Oztürk S; Richter P; Kammerer K; Schnölzer M; Krammer PH; Lavrik IN
    Mol Cell; 2012 Jul; 47(2):306-19. PubMed ID: 22683265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
    Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
    Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated c-Myc prematurely recruits both Type I and II CD95/Fas apoptotic pathways associated with terminal myeloid differentiation.
    Amanullah A; Liebermann DA; Hoffman B
    Oncogene; 2002 Feb; 21(10):1600-10. PubMed ID: 11896589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CAP3 in CD95 signaling: new insights into the mechanism of procaspase-8 activation.
    Golks A; Brenner D; Schmitz I; Watzl C; Krueger A; Krammer PH; Lavrik IN
    Cell Death Differ; 2006 Mar; 13(3):489-98. PubMed ID: 16179941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
    Grassi F; Piacentini A; Cristino S; Toneguzzi S; Facchini A; Lisignoli G
    Arthritis Rheum; 2004 Feb; 50(2):498-506. PubMed ID: 14872492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mathematical model of caspase function in apoptosis.
    Fussenegger M; Bailey JE; Varner J
    Nat Biotechnol; 2000 Jul; 18(7):768-74. PubMed ID: 10888847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model reduction of the intracellular-signaling subsystem of apoptosis.
    Bykov V; Gol'dshtein V
    Math Biosci; 2016 May; 275():39-50. PubMed ID: 26880618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
    Spierings DC; de Vries EG; Vellenga E; de Jong S
    Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD95(APO-1/Fas) DISC and beyond.
    Peter ME; Krammer PH
    Cell Death Differ; 2003 Jan; 10(1):26-35. PubMed ID: 12655293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis.
    Wagenknecht B; Roth W; Gulbins E; Wolburg H; Weller M
    Cell Death Differ; 2001 Jun; 8(6):595-602. PubMed ID: 11536010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parameter identification using stochastic simulations reveals a robustness in CD95 apoptotic response.
    Zimmer C; Schleich K; Lavrik I
    Mol Biosyst; 2016 Apr; 12(5):1486-95. PubMed ID: 27004466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas/CD95- and mitochondrial-mediated mechanism.
    Gajate C; An F; Mollinedo F
    Clin Cancer Res; 2003 Apr; 9(4):1535-45. PubMed ID: 12684430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD95-induced JNK activation signals are transmitted by the death-inducing signaling complex (DISC), but not by Daxx.
    Hofmann TG; Möller A; Hehner SP; Welsch D; Dröge W; Schmitz ML
    Int J Cancer; 2001 Jul; 93(2):185-91. PubMed ID: 11410864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly.
    Holmström TH; Schmitz I; Söderström TS; Poukkula M; Johnson VL; Chow SC; Krammer PH; Eriksson JE
    EMBO J; 2000 Oct; 19(20):5418-28. PubMed ID: 11032809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of CD95-induced apoptosis and NF-κB activation at the single cell level.
    Schmidt JH; Pietkiewicz S; Naumann M; Lavrik IN
    J Immunol Methods; 2015 Aug; 423():12-7. PubMed ID: 25967949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does CD95 have tumor promoting activities?
    Peter ME; Legembre P; Barnhart BC
    Biochim Biophys Acta; 2005 May; 1755(1):25-36. PubMed ID: 15907590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.